0IGA.L
Emergent BioSolutions Inc. is a life sciences enterprise dedicated to developing and delivering solutions for preparing for and responding to diverse public health threats (PHTs) in the United States. Its mission involves countering unforeseen, intentional, and naturally arising health crises affecting populations. The company's product portfolio addresses a wide spectrum of PHTs, encompassing chemical, biological, radiological, nuclear, and explosive agents (CBRNE), emergent infectious diseases, travel-related health concerns, and immediate emergency medical needs. Among its key commercialized offerings are: Vaccines: BioThrax (for anthrax), ACAM2000 (for smallpox), Vivotif (an oral immuniz...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2018-01-29
Stock Exchange
LSE
Ticker
0IGA.L
According to Emergent BioSolutions Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 4.90. This represents a change of 33.45% compared to the average of 3.67 of the last 4 quarters.
The mean historical PE Ratio of Emergent BioSolutions Inc. over the last ten years is 18.03. The current 4.90 PE Ratio has changed 2.62% with respect to the historical average. Over the past ten years (40 quarters), 0IGA.L's PE Ratio was at its highest in in the June 2021 quarter at 174.97. The PE Ratio was at its lowest in in the December 2018 quarter at -221.86.
Average
18.03
Median
14.04
Minimum
-2.80
Maximum
50.90
Discovering the peaks and valleys of Emergent BioSolutions Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.54%
Maximum Annual PE Ratio = 50.90
Minimum Annual Increase = -574.94%
Minimum Annual PE Ratio = -2.80
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 12.61 | -574.94% |
| 2024 | -2.66 | 1.54% |
| 2023 | -0.16 | -94.23% |
| 2022 | -2.80 | -126.40% |
| 2021 | 10.60 | -31.49% |
| 2020 | 15.47 | -69.60% |
| 2019 | 50.90 | 7.32% |
| 2018 | 47.42 | 102.06% |
| 2017 | 23.47 | -7.81% |
| 2016 | 25.46 | 3.71% |
The current PE Ratio of Emergent BioSolutions Inc. (0IGA.L) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
3.27
5-year avg
3.52
10-year avg
18.03
Emergent BioSolutions Inc.’s PE Ratio is greater than Esperion Therapeutics, Inc. (-131.40), greater than Verastem, Inc. (-2.98), greater than Iovance Biotherapeutics, Inc. (-13.37), greater than Anavex Life Sciences Corp. (-9.33), greater than Geron Corporation (-13.14), greater than Myriad Genetics, Inc. (-3.25), greater than Editas Medicine, Inc. (-3.52), greater than Aclaris Therapeutics, Inc. (-9.53), greater than Heron Therapeutics, Inc. (-1.68), greater than Abeona Therapeutics Inc. (-4.82),
| Company | PE Ratio | Market cap |
|---|---|---|
| -131.40 | N/A | |
| -2.98 | N/A | |
| -13.37 | N/A | |
| -9.33 | N/A | |
| -13.14 | N/A | |
| -3.25 | N/A | |
| -3.52 | N/A | |
| -9.53 | N/A | |
| -1.68 | N/A | |
| -4.82 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Emergent BioSolutions Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Emergent BioSolutions Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Emergent BioSolutions Inc.'s PE Ratio?
How is the PE Ratio calculated for Emergent BioSolutions Inc. (0IGA.L)?
What is the highest PE Ratio for Emergent BioSolutions Inc. (0IGA.L)?
What is the 3-year average PE Ratio for Emergent BioSolutions Inc. (0IGA.L)?
What is the 5-year average PE Ratio for Emergent BioSolutions Inc. (0IGA.L)?
How does the current PE Ratio for Emergent BioSolutions Inc. (0IGA.L) compare to its historical average?